HOLD with 15-20% trim into $605-610 resistance; structural thesis intact but deteriorating entry undermines conviction
HOLD is the disciplined application of competing binding lessons — 8/14 mandates partial trim (15-20%) on independent analyst convergence of technical deterioration; 8/13 prohibits over-trimming structurally durable names (PEG 1.26, beta 0.11, sticky $58.62B backlog, sole-source monopoly franchises). The 15-20% trim respects both. Entry at $593.74 is over $50 above both moving averages with MACD one bearish session from negative crossover; adding here is buying into resistance. Structural floor remains high ($11.7B annualized FCF, $6.91B FCF up 30% YoY, $11.44B deferred revenue up 17% YoY, 2.27% dividend yield, NATO commitments) but entry isn't. Patience over conviction; the company is fine, the entry isn't.
| Position | Action |
|---|---|
| Current price $593.74 vs. $605-610 resistance zone | Trim 15-20% to bank gains at proven resistance level |
| Close below $540 (50 SMA $543.90 and 200 SMA $546.48) | Hard invalidation stop - Death Cross breakdown voids structural thesis |
| MACD histogram reset / price correction to $560-580 | Re-add on weakness with first add at $580-585 |
| Further decline to $560-575 | Second add - between 50 SMA and bull's preferred entry |
| Price reaches $620-640 | Take profits - upper Bollinger / prior swing confluence, 7:1 reward-to-risk |
LMT's Q2 2026 EPS of $7.94 (up 5.4x YoY) and 23% backlog growth represent fundamental strength being ignored by analysts focused on short-term technical noise, making the current consolidation a buying opportunity.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $593.52 | neutral |
| 50 SMA | $543.90 | bullish |
| 200 SMA | $546.48 | bullish |
| RSI (14) | 59.49 | neutral |
| MACD | +17.99 | neutral |
| MACD Signal | +17.49 | neutral |
| MACD Histogram | +0.50 (collapsing from peak +7.2) | bearish |
| Bollinger Upper Band | $631.97 | neutral |
| Bollinger Middle Band (20 SMA) | $579.60 | neutral |
| Bollinger Lower Band | $527.24 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price reaches $580-585 (Bollinger middle / prior consolidation)
Then: First add - higher probability of being tested, respects technical signals
↩ rebuts: “Today's close was at the day's low — a bearish intraday signal”
EV: +5.4% · concedes: The easy money has been made from mid-$510s to $608; $580 represents a more attractive entry zone than current levels; A retest of $545 (200 SMA) would be an 8.2% drawdown — though characterized as a 'gift-buying opportunity'
The bull's "growth" narrative is built on base effects and buybacks, not operational improvement; revenue is flat, operating income is declining, and the technical setup is fragile with unfavorable risk/reward at current levels.
EV: -$8.2% (downside to $545) · concedes: NATO 3% commitments are real structural demand driver — but LMT isn't sole beneficiary (RTX won Tomahawk); Low beta does provide some insulation from market volatility; F-35 remains a structural monopoly regardless of cost overruns; Golden Cross confirmation (if it occurs) would be technically bullish
→ vs conservative: Death Cross framing is alarmist; LMT is nearly $50 above both moving averages and executing sharpest recovery in defense sector, not in bearish regime
→ vs conservative: "Trim into strength" at $605-610 is "borderline malpractice"; waiting for $545-$560 gives up 5-8% upside to chase 4% downside in a name executing this well
→ vs conservative: Fundamentals massively underweighted; Forward P/E of 18.15x with 20% earnings growth yields PEG under 1 for a monopoly franchise
→ vs neutral: MACD histogram compression from +6 to +0.50 seen as bullish digestion event, not bearish signal; light volume confirms accumulation, not distribution
→ vs neutral: Fundamental picture being "massively underweighted"; treating extraordinary catalyst pipeline as "moderately bullish" when it is actually extraordinary
| ATR (14-day) |
| $15.24 |
| neutral |
| Today's Volume | 673,338 (light) | bearish |
Support: 570 · 563 · 560 · 545 | Resistance: 600 · 607 · 608.68 · 615 · 620 · 631.97 · 632
LMT exhibits a mixed technical setup with a short-term uptrend intact but momentum decelerating sharply. Price closed at $593.74 (down ~2.5%), sitting just above the 10 EMA ($593.52) as its first dynamic support, while remaining well above the 50 SMA ($543.90, +9.1%) and 200 SMA ($546.48, +8.7%). The critical concern is the collapsing MACD histogram (+7.2 peak to +0.50), which risks a bearish crossover if MACD drops below the signal line ($17.49) on continued selling. RSI has normalized to 59.49 (neutral) after cooling from overbought territory (71.65 on 7/24). The 50 SMA remains slightly below the 200 SMA, meaning the Golden Cross has not yet confirmed despite the rally. Volume on today's pullback was light (673K), which is less alarming than heavy selling but lacks buy-the-dip conviction. ATR has compressed to $15.24, suggesting the stock is in a digestion phase following the July 23 gap-up from $508-$520 to $568.59 (+10.5%).
Market Cap
$137.0B
Implied Share Price
~$593
Shares Outstanding
~231M
P/E (TTM)
21.87x
Forward P/E
18.15x
P/B
15.57x
PEG Ratio
1.26
FCF Yield
4.06%
Dividend Yield
2.27%
Beta
0.11
52-Week High
$692.00
52-Week Low
$437.25
50-Day MA
$542.41
200-Day MA
$550.10
TTM Revenue
$77.0B
FY2025 Revenue
$75.05B
FY2025 Gross Profit
$7.62B
FY2025 Operating Income
$7.73B
FY2025 Net Income
$5.02B
FY2025 Diluted EPS
$21.49
FY2025 EBITDA
$8.73B
Operating Margin (TTM)
11.96%
Net Margin (TTM)
8.16%
Gross Margin
11.8%
ROE (TTM)
89.2%
ROA (TTM)
8.64%
Current Ratio
1.19
Total Assets
$62.45B
Total Debt
$20.54B
Net Debt
$16.75B
Stockholders' Equity
$8.77B
Cash & Equivalents
$3.79B
Working Capital
$4.59B
Current Deferred Revenue
$12.15B
Pension Obligations
$3.93B
D/E Ratio
234%
FCF (FY2025)
$6.91B
FCF (Q2 2026)
$2.92B
Operating Cash Flow (FY2025)
$8.56B
CapEx (FY2025)
-$1.65B
Dividends Paid (FY2025)
-$3.13B
Share Buybacks (FY2025)
-$3.00B
Revenue 5Y CAGR
~2.7%
Forward EPS Growth
~20%
Forward EPS Estimate
$32.72
Q2 2026 EPS
$7.94
Q2 2026 Revenue
$20.06B
Q2 2026 Net Income
$1,836M
Q2 2025 EPS
$1.46
Tangible Book Value
$-4.3B
Strengths
Concerns
Lockheed Martin is a financially healthy, cash-generative defense prime executing a strong operational recovery from a Q2 2025 program charge, with Q2 2026 representing its best quarter in years. The combination of +23% YoY backlog increase, -18% net debt reduction, and 5.4x YoY EPS recovery paints a bullish fundamental picture. Trading at ~$593 near both 50-day and 200-day moving averages, the stock offers a Forward P/E of 18.15x with ~20% expected earnings growth and attractive FCF yield of 4.06%, supporting a HOLD-to-BUY stance with preference for buy-on-dip given current sideways action near key moving averages and 52-week range of $437-$692.
Macro: Rising long-term Treasury yields at multi-year highs, oil prices elevated with 40% probability of WTI reaching $90, prediction markets pricing 85% odds of no Fed rate cuts during 2026, but recession odds remain low at 8%. Geopolitical tensions elevated: Russia-Ukraine ceasefire probability has declined to 26% (down 7.5 points), U.S.-Iran nuclear agreement probability is just 2% by September 30, and Hormuz normalization probability is 32%. Broad Tomahawk award of $22.9 billion to RTX illustrates sector-wide production surge.